Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations

Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations

Background: An issue related to the terms of assignment of genetically engineered biological agents to patients with juvenile idiopathic arthritis (JIA) still remains debatable in pediatric rheumatology.Objective: Our aim was to evaluate the efficacy and safety of etanercept therapy in early and lat...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: T. M. Bzarova, E. I. Alexeeva, S. I. Valieva, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, A. N. Fetisova, N. I. Taibulatov
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: "Paediatrician" Publishers LLC 2015-09-01
Ráidu:Вопросы современной педиатрии
Fáttát:
children
juvenile idiopathic arthritis
early arthritis
late arthritis
etanercept
Liŋkkat:https://vsp.spr-journal.ru/jour/article/view/1079

Interneahtta

https://vsp.spr-journal.ru/jour/article/view/1079

Geahča maid